Then, overnight, those three dots became hundreds of dots all over my body like a red ... the biopsy came back identifying plaque psoriasis, a chronic autoimmune skin condition that manifests ...

Vulgaris is the Latin word for “common.” Plaque psoriasis on your feet causes similar symptoms as when it develops on other parts of your body. It’s characterized by raised patches of dry ...

Investigators compared outcomes among patients with psoriasis undergoing apremilast treatment with genital involvement versus those without genital involvement.

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

The recommended dose of Cimzia for adults with moderate-to-severe plaque psoriasis is 400 mg (given as two subcutaneous injections of 200 mg each) every other week. For some patients (with body ...

ESK-001, a tyrosine kinase 2 inhibitor, may be a promising new oral treatment for plaque psoriasis. Patients taking ESK-001 twice daily maintained skin clearance up to a year. ORLANDO — Patients ...

Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ulcerative colitis successfully met all primary endpoints. Johnson & Johnson’s ...

Once-daily ICP-488 significantly improved PASI scores in patients with plaque psoriasis compared with placebo at week 12. The safety profile of ICP-488 was similar to placebo. ORLANDO — A once ...

While the Big Pharma didn’t drill down into the data for the Iconic-Advance 1&2 studies, the company did use the conference to reinforce the findings from a previous phase 3 plaque psoriasis win ...

(RTTNews) - Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO ...

These data add to the large body ... Body Psoriasis: Improvements in Patient-Reported Outcomes (ARRECTOR) Gooderham, M et al. ZORYVE cream, 0.3%, is indicated for topical treatment of plaque ...